Dr. Niko Kriegeskorte, a computational neuroscientist from the Zuckerman Institute at Columbia University, discusses the challenges of deriving insight into the principles of brain function using fMRI and other neuroimaging methods.
Source: nimh

In this Director’s message, Dr. Gordon digs into the historical roots of the hippocampus and the role it plays in human memory – an example of how scientists build upon past research discoveries and, in turn, advance the science that could benefit future generations.
Source: nimh

One of the most horrific—and least acknowledged—effects of mass incarceration is the epidemic of mental illness in our jails and prisons. On June 13, 2019, Alisa Roth, journalist and author of Insane: America’s Criminal Treatment of Mental Illness, will explain how this happened—and how we can fix it. Phil Andrews is the Director of Crime Prevention Initiatives for the State’s Attorney’s Office of Montgomery County, Maryland. In January 2016, a Task Force chaired by Andrews released a report unanimously recommending the establishment of mental health courts at the Circuit and District levels to divert people who commit low-level crimes as a product of mental illness into treatment and services and away from prosecution and incarceration.
Source: nimh

On June 5th and 6th, investigators will meet to identify and prioritize research needs in the application of predictive analytics using electronic health records in suicide prevention.
Source: nimh

The goal of this initiative is to encourage researchers to utilize invasive neural recording opportunities in humans to study the neural circuity underlying mental health disorders.
Source: nimh

The purpose of the Conte Centers program is to support interdisciplinary teams of researchers engaged in novel, creative, and integrated experimental approaches to address high-risk, high-impact scientific questions in either basic neuroscience research or in translational research that will significantly advance the state of the science in brain and behavioral research to ultimately provide the foundation for understanding mental disorders and/or transform the understanding and treatment of mental illnesses, as well as developing data and other research resources that are available to the scientific community to further advance research in this field.
Source: nimh

The goal of the NCDDG Program is to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders, substance use disorders (SUDs), or alcohol addiction, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets.
Source: nimh

The goal of this initiative is to support grant applications in two related but distinct areas. The first area involves developing and testing novel tools and methods of neuromodulation that go beyond the existing forms of neural stimulation. The second area involves the optimization of existing stimulation methods.
Source: nimh

The goal of this initiative is to support the identification, validation and manipulation of neural circuits that underlie cognitive, emotional, and social processes impacted in mental illnesses. The initiative is focused on probing psychiatrically relevant behavior through studies in non-human primates. This initiative is intended to complement existing NIMH-funded preclinical investigation of circuits which have often focused on smaller brains.
Source: nimh

Principal Investigator and Chief of the Behavioral Endocrinology Branch, Dr. Peter Schmidt, Research Fellow Dr. Shau-Ming Wei, and Postdoctoral Fellow Dr. Kathy Reding, discuss the typical pubertal transition, how puberty affects brain development, what changes parents might expect in their children, and what NIMH hopes to learn from the research.
Source: nimh